Neurocrine Biosciences (NBIX) Tops Q3 EPS by 49c ; Offers Guidance
Tweet
Share
E-mail
Get Alerts NBIX Hot Sheet
Price: $154.12 +0.92%
Financial Fact:
General and administrative: 17.49M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
General and administrative: 17.49M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q3 EPS of $1.54, $0.49 better than the analyst estimate of $1.05. Revenue for the quarter came in at $498.8 million versus the consensus estimate of $478.85 million.
GUIDANCE:
Neurocrine Biosciences sees FY2023 revenue of $1.82-1.84 billion, versus the consensus of $1.86 billion.
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- Motorsport Games Inc. (MSGM) Tops Q2 EPS by 33c
- Securitize Corp (SECZ) PT Lowered to $10 at Benchmark as Stock Plummets Post Q2 Earnings
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
